Sun Pharmaceutical, which had initiated acquisition of Taro Pharmaceutical Industries four-and-a-half years ago, made a proposal to be the 100 per cent owner of the West Asian drug company. After about three years of legal battle, Sun had in last September completed the acquisition of controlling stake in the Israeli firm. Today, Sun Pharma, the country’s largest drugmaker by market cap, owns 66 per cent in Taro.Sun has offered to buy all of the outstanding shares it does not own in Taro — for $24.40 a share. Tts offer represents 25.96 per cent premium over the most recent closing of the Israeli firm's common stock. The offer is subject to the approval of Taro Board and other regulatory authorities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.00 |
| Dr. Reddys Lab | 1295.00 |
| Cipla | 1321.95 |
| Zydus Lifesciences | 946.80 |
| Lupin | 2271.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: